Fatty Liver in Hormone Receptor-Positive Breast Cancer and Its Impact on Patient's Survival

CONCLUSION: The development of NAFLD during treatment in patients with HR+/HER2- breast cancer was associated with several independent risk factors: being overweight, waist circumference, triglycerides, and LDL-C. Interestingly, breast cancer patients with NAFLD during treatment had longer DFS than those without NAFLD.PMID:34652078 | DOI:10.4048/jbc.2021.24.e41

Source: Journal of Breast Cancer - October 15, 2021 Category: Cancer & Oncology Authors: Kartika Widayati Taroeno-Hariadi Yasjudan Rastrama Putra Lina Choridah Irianiwati Widodo Mardiah Suci Hardianti Teguh Aryandono Source Type: research